Final Tuxedo-3 data presented at ESMO 2026 in Madrid show median overall survival of 10.5 months for patients with leptomeningeal disease. The phase II results indicate intracranial activity in active brain metastases but need confirmation in larger prospective trials.
A reported Spanish consensus would make continuous glucose monitoring routine for some people with type 2 diabetes who use basal insulin. International guidance supports considering CGM for insulin-treated patients, while the Spanish figures await confirmation against the source document.
Austria and Switzerland led Europe in the use of newer cancer medicines in 2023, while Spain stayed in the middle. Approval and funding still do not guarantee that patients receive treatment quickly.
More than 40 young specialists met in Madrid for Emerging Experts. The programme focused on chronic hypoparathyroidism and the decisions that go beyond calcium control.
Spanish doctors and researchers credit medical new idea and close cooperation between researchers and the pharmaceutical industry with extending the lives of patients with multiple myeloma. Event participants have described survival gains as threefold, and some patients achieve functional remission, though the claim is not a confirmed national average.
Spain records about 285,000 fragility fractures each year. Specialists say too many eligible patients still miss treatment and follow-up after a first fracture.
At Hospital Universitario Fundación Jiménez Díaz, specialists showed patients and trainees how hematology care draws on blood counts and cellular studies, with genetic tests adding further detail. The meeting also covered new treatments and transfusion support, alongside research and patient services.
Vitamin D levels may fall as October brings less useful sunlight, but no Spanish study cited here confirms that more than 60% of Spanish adults are affected. Testing matters because excess supplements can damage health.
Researchers in Barcelona identified p38a as a possible target in melanoma. Blocking the protein strengthened anti-PD-1 treatment in animal models and sometimes cleared tumours completely, but the findings remain preclinical.
A Vall d'Hebron study points to p38a as a possible melanoma treatment target. Blocking the protein improved anti-PD-1 therapy in animal models, while a nine-gene profile may help identify tumours more likely to respond.
Roche has begun selling Xofluza in Spain. The oral antiviral blocks flu replication early and is taken in one dose within 48 hours.
Vall d'Hebron researchers identified p38α as a possible target in melanoma treatment. Blocking the protein improved anti-PD-1 responses in experimental models and revealed a nine-gene signature linked to treatment outcomes.
Researchers at Vall d’Hebron found that blocking p38α improved anti-PD-1 treatment in melanoma models. The work also identified a nine-gene signature linked to treatment response and survival.
Meningitis can worsen quickly, and its first signs may look ordinary. High fever and severe headache, especially with neck stiffness, need urgent medical assessment.
The European Commission has approved ICOTYDE® for eligible psoriasis patients aged 12 and over who weigh at least 40kg. The once-daily oral peptide targets IL-23 directly and is backed by phase III data from about 2,500 participants.
More than 350 specialists met in Barcelona to discuss earlier rheumatoid arthritis diagnosis. Biomarkers and ultrasound are helping doctors spot the disease sooner and tailor treatment for thousands of patients in Spain.
Lenzetto shortages are disrupting access to transdermal hormone treatments in Spain. Alternative patches are under pressure as regulators seek more supply and clinical guidance.
Around 20,000 new cases are diagnosed in Spain each year. Earlier detection and targeted therapies are helping doctors protect mobility and quality of life.
GETECCU and ACCU España have presented a ten-point plan for inflammatory bowel disease care in Spain. The groups say access to specialist units and treatment still varies between autonomous communities.
A six-year CNIO study identified a brief period when early brain metastases become vulnerable. Three drugs eliminated micrometastases in animal models, and researchers also tested their effects in human tissue.
CNIO researchers found a short stage when early brain metastases are unusually vulnerable. Three drugs removed micrometastases in animal models before they developed into detectable tumours.
VHIO researchers found tumour neoantigens and responsive T cells in blood samples. The method could widen access to personalised immunotherapy when tumours are hard to biopsy.
Spanish researchers have identified a brief stage when early brain metastases may respond to treatment. Three drugs eliminated microscopic lesions in mice and showed therapeutic effects in human tissue, but clinical trials are still needed.
CNIO researchers identified a short period when early brain metastases are unusually vulnerable. Three drugs destroyed micrometastases in laboratory models before they became detectable tumours.
Spain has begun funding its first dual immunotherapy for first-line treatment of metastatic colorectal cancer. The combination targets a rare tumour subtype and produced major gains over chemotherapy in a phase III trial.
Auditors found Toledo’s psoriasis unit met 33 basic indicators and 15 excellence indicators under the AEDV’s Cuderma programme. The review covered patient education and follow-up, while also examining cooperation between medical teams.
Gedeon Richter has launched Tu Salud Ósea for people with osteoporosis in Spain. The app tracks treatment doses and brings exercise and nutrition guidance into daily care, alongside information about the disease.
Covid, flu and colds are spreading more as schools and workplaces return to normal. The basic trigger is renewed close contact, not the arrival of autumn itself.
Spain's endocrinologists want cascade screening for familial hypercholesterolaemia. Testing close relatives can uncover silent cases early and prevent years of exposure to dangerously high cholesterol.
A new analysis finds that semaglutide protects the heart in ways weight loss alone cannot explain. Traditional risk factors account for no more than half of the reduction in cardiovascular disease seen in the international SELECT trial.
Spain is considering newborn screening for familial hypercholesterolaemia. A low-cost test could identify affected children and prompt checks for relatives before heart disease appears.
Restless legs syndrome may affect up to 10% of adults and around 4% of children and adolescents. In children, it is often mistaken for growing pains, and diagnosis can take more than a decade.
A Spanish-led treatment cleared a stubborn battlefield infection. The patient avoided amputation and regained some elbow movement after receiving a bacteriophage alongside colistin.
More than two million people in Spain may have restless legs syndrome. Up to 90% of cases may go undiagnosed while symptoms disrupt sleep and daily rest.
Spanish researchers corrected a faulty DNA reading signal in human cells. The change restored part of an enzyme needed for metabolism, though a possible treatment is still years away.
